Cutaneous Aspergillus Ustus in a Lung Transplant Recipient: Emergence of a New Opportunistic Fungal Pathogen

Journal of Heart and Lung Transplantation

Volumn 27, Issue 1, 2008, Pages 131-134

  Vagefi, Parsia A ^a   Cosimi, A Benedict ^a   Ginns, Leo C ^a   Kotton, Camille N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; POSACONAZOLE; TERBINAFINE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS USTUS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PUNCH BIOPSY;

ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; ASPERGILLOSIS; ASPERGILLUS; BIOPSY; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTIONS;

EID: 37549040573     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.09.020     Document Type: Article

References (18)

1. Panackal A.A., Imhof A., Hanley E.W., and Marr K.A. Aspergillus ustus infections among transplant recipients. Emerg Infect Dis 12 (2006) 403
2. Stiller M.J., Teperman L., Rosenthal S.A., et al. Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J Am Acad Dermatol 31 (1994) 344
3. Mehrad B., Paciocco G., Martinez F.J., et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 119 (2001) 169
4. Minari A., Husni R., Avery R.K., et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transplant Infect Dis 4 (2002) 195
5. Dummer J.S., Lazariashvilli N., Barnes J., Ninan M., and Milstone A.P. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 23 (2004) 1376
6. Pfeiffer C.D., Fine J.P., and Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 42 (2006) 1417
7. Pickering J.W., Sant H.W., Bowles C.A., Roberts W.L., and Woods G.L. Evaluation of a (1→3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43 (2005) 5957
8. Pazos C., Ponton J., and Del Palacio A. Contribution of (1→3)-beta-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43 (2005) 299
9. Lin S.J., Schranz J., and Teutsch S.M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32 (2001) 358
10. Patterson T.F., Kirkpatrick W.R., White M., et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79 (2000) 250
11. Verweij P.E., van den Bergh M.F., Rath P.M., et al. Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol 37 (1999) 1606
12. Pavie J., Lacroix C., Hermoso D.G., et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 43 (2005) 4902
13. Azzola A., Passweg J.R., Habicht J.M., et al. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection. J Clin Microbiol 42 (2004) 4805
14. Herbrecht R., Denning D.W., Patterson T.F., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347 (2002) 408
15. Betts R., Glasmacher A., Maertens J., et al. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. Cancer 106 (2006) 466
16. Araujo R., Goncalves Rodrigues A., and Pina-Vaz C. Susceptibility pattern among pathogenic species of Aspergillus to physical and chemical treatments. Med Mycol 44 (2006) 439
17. Maertens J., Glasmacher A., Herbrecht R., et al. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 107 (2006) 2888
18. Walsh T.J., Raad I., Patterson T.F., et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 44 (2007) 2